Hem › Hjärtsvikt › Arizona › Phoenix
Kliniska studier för Hjärtsvikt i Phoenix, AZ
18 studier för Hjärtsvikt söker deltagare vid platser i och runt Phoenix (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
ELEVATE-HFpEF Clinical Study
Rekryterar
- Banner - University Medical Center Phoenix, Phoenix
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RekryterarFas 3
- Research Site, Phoenix
- Research Site, Phoenix
BiVACOR® Total Artificial Heart Early Feasibility Study
Rekryterar
- Banner - University Medical Center Phoenix, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekryterarFas 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
RekryterarFas 3
- Phoenix, AZ Investigative Site CON-10115, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekryterarFas 3
- Phoenix, AZ Investigative Site 10115, Phoenix
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Rekryterar
- Mayo Clinic Phoenix, Phoenix
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Rekryterar
- Banner--University Medical Center Phoenix, Phoenix
- Mayo Clinic - Arizona, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekryterarFas 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Assessment of CCM in HF With Higher Ejection Fraction
Rekryterar
- Arizona Heart Rhythm, Phoenix
- Cardiovascular Consultants, Ltd, Phoenix
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RekryterarFas 3
- Phoenix, AZ Investigative Site FIN-10115, Phoenix
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekryterar
- St. Joseph's Hospital and Medical Center, Phoenix
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekryterar
- Banner-University Medical Center Phoenix, Phoenix
CCM OPEN HF Registry
RekryterarObservationsstudie
- University of Arizona and Banner University Medical Center Phoenix, Phoenix
- HonorHealth Research Institute, Phoenix
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekryterar
- Banner Health - Phoenix, Phoenix
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Rekryterar
- Arizona Heart Foundation, Phoenix
His-Bundle Corrective Pacing in Heart Failure
Rekryterar
- University of Arizona, Phoenix
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
RekryterarFriska volontärer välkomna
- Multiple Locations, Phoenix
Hjärtsvikt-studier i andra städer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Houston, TX36 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- St. Louis, MO26 studier
- Durham, NC26 studier
- Kansas City, MO25 studier
- Atlanta, GA25 studier
Andra studier i Phoenix
- Bröstcancer25 studier
- Kolorektal cancer25 studier
- Övervikt22 studier
- Icke-småcellig lungcancer20 studier
- Metastaserande cancer20 studier
- Prostatacancer17 studier
- Cancer (alla typer)17 studier
- Multipelt myelom16 studier
- Bukspottkörtelcancer16 studier
- Hjärt-kärlsjukdom16 studier
- Alzheimers sjukdom15 studier
- Övervikt15 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.